Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children Aged 10 to Less Than 18 Years

NCT01035749 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

310

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: GSK Biologicals' Influenza investigational vaccine GSK2340274A
BIOLOGICAL: GSK Biologicals' Influenza investigational vaccine GSK2340273A
BIOLOGICAL: Placebo (saline)

Sponsor

GlaxoSmithKline